Marc‐André D’Aoust

机构：Medicago (Canada)

发表论文 59 篇 · 总被引 2969 次 · h-index 26

代表论文

• Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19 (2021 · Nature Medicine · 被引 319)
• Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates (2022 · Cellular and Molecular Immunology · 被引 60)
• Plant molecular farming in the wake of the closure of Medicago Inc (2023 · Nature Biotechnology · 被引 37)
• Safety and immunogenicity of an AS03-adjuvanted plant-based SARS-CoV-2 vaccine in Adults with and without Comorbidities (2022 · npj Vaccines · 被引 37)
• Phase 2 Randomized Trial of an AS03 Adjuvanted Plant-Based Virus-Like Particle Vaccine for Covid-19 in Healthy Adults, Older Adults and Adults with Comorbidities (2021 · medRxiv · 被引 35)
• Molecular responses of agroinfiltrated Nicotiana benthamiana leaves expressing suppressor of silencing P19 and influenza virus‐like particles (2023 · Plant Biotechnology Journal · 被引 29)